Choice of treatment evaluated after trial periods with bone conduction devices and contralateral routing of sound systems in patients with <scp>single‐sided</scp> deafness

Wendrich, Anne W.; Heteren, Jan A. A. van; Peters, Jeroen P. M.; Cattani, Guido; Stokroos, Robert J.; Versnel, Huib; Smit, A.L.

doi:10.1002/lio2.1002

Cited by 3 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Discomfort with the device, concerns about sound quality, and subjective auditory impairment are among the main reasons for rejecting CROS and BCD [73,74]. Reluctance to use redirecting devices is also linked to changes in self-perception, aesthetic concerns, and the presence of negative stereotypes.…”

Section: Bone Conduction Devices (Bcd): Surgically Implanted Devicesmentioning

confidence: 99%

Single-Sided Deafness and Hearing Rehabilitation Modalities: Contralateral Routing of Signal Devices, Bone Conduction Devices, and Cochlear Implants

Pantaleo,

Murri,

Cavallaro

et al. 2024

Brain Sciences

View full text Add to dashboard Cite

Single sided deafness (SSD) is characterized by significant sensorineural hearing loss, severe or profound, in only one ear. SSD adversely affects various aspects of auditory perception, including causing impairment in sound localization, difficulties with speech comprehension in noisy environments, and decreased spatial awareness, resulting in a significant decline in overall quality of life (QoL). Several treatment options are available for SSD, including cochlear implants (CI), contralateral routing of signal (CROS), and bone conduction devices (BCD). The lack of consensus on outcome domains and measurement tools complicates treatment comparisons and decision-making. This narrative overview aims to summarize the treatment options available for SSD in adult and pediatric populations, discussing their respective advantages and disadvantages. Rerouting devices (CROS and BCD) attenuate the effects of head shadow and improve sound awareness and signal-to-noise ratio in the affected ear; however, they cannot restore binaural hearing. CROS devices, being non-implantable, are the least invasive option. Cochlear implantation is the only strategy that can restore binaural hearing, delivering significant improvements in speech perception, spatial localization, tinnitus control, and overall QoL. Comprehensive preoperative counseling, including a discussion of alternative technologies, implications of no treatment, expectations, and auditory training, is critical to optimizing therapeutic outcomes.

show abstract

Section: Bone Conduction Devices (Bcd): Surgically Implanted Devicesmentioning

confidence: 99%

Single-Sided Deafness and Hearing Rehabilitation Modalities: Contralateral Routing of Signal Devices, Bone Conduction Devices, and Cochlear Implants

Pantaleo,

Murri,

Cavallaro

et al. 2024

Brain Sciences

View full text Add to dashboard Cite

show abstract

Brazilian Society of Otology task force – single sided deafness – recommendations based on strength of evidence

Tsuji,

Hamerschmidt,

Lavinsky

et al. 2024

Brazilian Journal of Otorhinolaryngology

View full text Add to dashboard Cite

Tinnitus reduction in patients with single-sided deafness: the effect of cochlear implantation, bone conduction devices, and contralateral routing of sound hearing aids investigated in a randomized controlled trial

Wendrich,

Assouly,

van Heteren

et al. 2024

Front. Neurol.

View full text Add to dashboard Cite

ObjectivesSingle-sided deafness (SSD) is often accompanied by tinnitus, resulting in a decreased quality of life. Currently, there is a lack of high level of evidence studies comparing different treatment options for SSD regarding tinnitus reduction. This randomized controlled trial (RCT) evaluated the effect of a cochlear implant (CI), bone conduction device (BCD), contralateral routing of sound (CROS), and no treatment on tinnitus outcomes in SSD patients, with follow-up extending to 24 months.MethodsA total of 120 adult SSD patients were randomized to three groups: CI, a trial period with first a BCD on a headband, then a CROS, or vice versa. After the trial periods, patients opted for a BCD, CROS, or no treatment. At the start of follow-up, 28 patients were implanted with a CI, 25 patients with a BCD, 34 patients had a CROS, and 26 patients chose no treatment. The Tinnitus Handicap Inventory (THI), Tinnitus Questionnaire (TQ), the Visual Analog Scale (VAS), and the Hospital Anxiety and Depression Scale (HADS) were completed at baseline and at 3, 6, 12, and 24 months of follow-up.ResultsThe CI and BCD groups showed significantly decreased tinnitus impact scores. The CI group showed the largest decrease, which was already observed at 3 months of follow-up. Compared to the baseline, the median THI score decreased by 23 points, the TQ score by 17 points, and the VAS score by 60 points at 24 months. In the BCD group, the TQ score decreased by 9 points, and the VAS decreased by 25 points at 24 months. The HADS anxiety and depression subscale showed no indication for anxiety or depression at baseline, nor at 24 months, for all groups.ConclusionIn this RCT, SSD patients treated with a CI or BCD showed an overall decrease in tinnitus impact scores up to 24 months compared to baseline. The CI group reported a stable and the largest reduction. Cochlear implants appear to be superior to BCD and CROS, and no treatment for achieving partial or complete resolution of tinnitus in patients with SSD.Clinical trial registrationNetherlands Trial Register, www.onderzoekmetmensen.nl/nl/trial/26952, NTR4457, CINGLE trial.

show abstract

Choice of treatment evaluated after trial periods with bone conduction devices and contralateral routing of sound systems in patients with single‐sided deafness

Cited by 3 publications

References 31 publications

Single-Sided Deafness and Hearing Rehabilitation Modalities: Contralateral Routing of Signal Devices, Bone Conduction Devices, and Cochlear Implants

Single-Sided Deafness and Hearing Rehabilitation Modalities: Contralateral Routing of Signal Devices, Bone Conduction Devices, and Cochlear Implants

Brazilian Society of Otology task force – single sided deafness – recommendations based on strength of evidence

Tinnitus reduction in patients with single-sided deafness: the effect of cochlear implantation, bone conduction devices, and contralateral routing of sound hearing aids investigated in a randomized controlled trial

Contact Info

Product

Resources

About